Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes

被引：6

作者：

Xiao, Qian ^{[1
,2
]}

Wang, Dan ^{[1
,2
]}

Li, Danyang ^{[2
]}

Huang, Jing ^{[1
,2
]}

Ma, Feifei ^{[1
,3
]}

Zhang, Haocheng ^{[1
,4
]}

Sheng, Yingda ^{[1
,2
]}

Zhang, Caimei ^{[1
,2
]}

Ha, Xiaoqin ^{[1
,2
]}

机构：

[1] Chinese Peoples Liberat Army Joint Secur Force, Dept Lab, Forty Hosp 9, 333 Nanbinhe Middle Rd, Lanzhou 730050, Gansu, Peoples R China

[2] Gansu Univ Tradit Chinese Med, Sch Publ Hlth, Lanzhou 730000, Gansu, Peoples R China

[3] Gansu Agr Univ, Coll Vet Med, Lanzhou 730070, Gansu, Peoples R China

[4] Lanzhou Univ, Sch Clin Med 2, Lanzhou 730030, Gansu, Peoples R China

来源：

JOURNAL OF DIABETES AND ITS COMPLICATIONS | 2023年 / 37卷 / 09期

基金：

中国国家自然科学基金;

关键词：

Protein kinase C; Diabetes mellitus; Endothelial cell; Oxidative stress; Inflammation; AMYLOID PRECURSOR PROTEIN; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; DELTA-PKC; POTASSIUM CHANNELS; ACTIVATION; INHIBITION; GLUCOSE; PHOSPHORYLATION; MECHANISMS;

D O I：

10.1016/j.jdiacomp.2023.108565

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Protein kinase C (PKC) is a family of serine/threonine protein kinases that play an important role in many organs and systems and whose activation contributes significantly to endothelial dysfunction in diabetes. The increase in diacylglycerol (DAG) under high glucose conditions mediates PKC activation and synthesis, which stimulates oxidative stress and inflammation, resulting in impaired endothelial cell function. This article reviews the contribution of PKC to the development of diabetes-related endothelial dysfunction and summarizes the drugs that inhibit PKC activation, with the aim of exploring therapeutic modalities that may alleviate endothelial dysfunction in diabetic patients.

引用

页数：8

共 50 条

[21] Endothelial dysfunction as a novel therapeutic target in atherosclerosis
Shimokawa, H
DRUG NEWS & PERSPECTIVES, 1999, 12 (05) : 271 - 277
[22] Endothelial dysfunction: a therapeutic target in bacterial sepsis?
Vincent, Jean-Louis
Ince, Can
Pickkers, Peter
EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (09) : 733 - 748
[23] Endothelial dysfunction as a therapeutic target -: The ENCORE trials
Lüscher, TF
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2000, 2 (0D) : D20 - D25
[24] The Therapeutic Implications of Protein Kinase C Inhibition in Endothelial Dysfunction Induced by Cardioplegic-Ischemia/Reperfusion Injury
Kim, Justin
Shi, Guangbin
Zhao, Amy
Sellke, Frank
Feng, Jun
BIOPHYSICAL JOURNAL, 2019, 116 (03) : 131A - 131A
[25] Human cytomegalovirus pUL135 protein: A potential therapeutic target in renal disease induced by endothelial cell dysfunction?
Chen, Cui
Liu, Juan
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 417
[26] Apelin/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases
Cheng, Jun
Luo, Xuling
Huang, Zhen
Chen, Linxi
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 12149 - 12160
[27] VAMP8 as a biomarker and potential therapeutic target for endothelial cell dysfunction in atherosclerosis
Yang, Luqun
Guan, Xin
Cheng, Jiangwei
Ni, Lin
Yao, Huijing
Gao, Yuping
Zhu, Kaiyi
Shi, Xiushan
Li, Bingjie
Lin, Yuanyuan
GENE, 2025, 942
[28] Sphingosine-1-Phosphate: A Potential Biomarker and Therapeutic Target for Endothelial Dysfunction and Sepsis?
Winkler, Martin S.
Nierhaus, Axel
Poppe, Annika
Greiwe, Gillis
Graeler, Markus H.
Daum, Guenter
SHOCK, 2017, 47 (06): : 666 - 672
[29] Endothelial cell dysfunction is a new potential therapeutic target for the treatment of critical limb ischemia
Renault, Marie-Ange
Caradu, Caroline
Couffinhal, Thierry
Gadeau, Alain-Pierre
JOURNAL OF VASCULAR RESEARCH, 2017, 54 : 65 - 66
[30] THE POTENTIAL OF PROTEIN-KINASE-C AS A TARGET FOR ANTICANCER TREATMENT
BASU, A
PHARMACOLOGY & THERAPEUTICS, 1993, 59 (03) : 257 - 280

← 1 2 3 4 5 →